Synergistic Remission of refractory cutaneous T-cell lymphoma by linperlisib plus venetoclax via targeting the PI3K/AKT/CREB-BCL-2/MCL-1 signaling axis.
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Yuxian Huang, Ziwei Liu, Jiayue Wei, Yinjie Qin, Yingzhi He, Yeqin Zheng, Yuchang Lin, Zhiming Li, Yuhua Li
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417016739
